Loading...
NPI 1104402254 · Farmington Hills, MI · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Bioprecision Laboratories, Inc. is a clinical medical laboratory provider located in Farmington Hills, Michigan. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Bioprecision Laboratories, Inc. |
| Address | 30000 Orchard Lake Rd Ste C |
| City | Farmington Hills |
| State | MI |
| ZIP | 48334 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 19, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $7M |
| Medicaid | $1.4K |
The provider’s billing is almost entirely tied to a single service line: K1034 (provision of covid-19 test, nonprescription self-administered and self-collected use). The code description and the revenue breakdown indicate the organization is operating primarily as a high-volume supplier/claim filer for self-administered COVID-19 test kits rather than a diversified clinical testing laboratory with a broad panel mix.
Medicare revenue is highly concentrated: the precomputed top-3 Medicare codes account for 100.0% of this provider’s Medicare revenue, and K1034 alone is reported with $7.1M in revenue (100.0% of this provider's total Medicare revenue). This concentration means changes in reimbursement or coding guidance for K1034 would have an outsized impact on the provider’s Medicare receipts.
On Medicare volume and standing the provider is an extreme outlier: K1034 shows 592.9K claims with an average paid/claim of $12, generating $7.1M in Medicare revenue, and the provider ranks #70 of 30143 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code). That national-level rank signals dominant scale for this specific COVID self-test provision activity relative to peers.
Medicaid activity is minimal in absolute scale but also concentrated: precomputed top-3 Medicaid codes account for 100.0% of Medicaid revenue, and the single reported Medicaid K1034 line shows 844 claims at $2 avg paid/claim and $1.7K in revenue. In-state competitive standing for that Medicaid line is modest—ranked #4 of 9 providers in-state (63th percentile; typical, unremarkable volume for this code).
The payer mix is effectively Medicare-dominated: lifetime Medicare revenue is $7M versus lifetime Medicaid revenue of $1.4K, indicating the provider operates with near-exclusive reliance on Medicare for topline billing. This skewed mix suggests limited exposure to Medicaid payer contracts and high sensitivity to Medicare policy and reimbursement changes for K1034.
Reimbursement and volume profile points to a low-dollar, high-volume business model on Medicare: Medicare K1034 shows $12 avg paid/claim against 592.9K claims to produce $7.1M, while Medicaid shows much lower per-claim payment ($2) and trivial aggregate receipts. The disparity between per-claim payments and the massive Medicare claim count underscores a throughput-driven revenue strategy rather than high-margin diagnostic testing.
NPI tenure is recent relative to many established labs: the NPI was enumerated on 2021-03-19 (~5 years ago). Achieving the reported Medicare scale (592.9K K1034 claims) since that enumeration date indicates rapid operational scaling focused on the COVID self-test provision line.
Because revenue and claims are nearly 100.0% driven by K1034 across both payers, the provider’s commercial and regulatory risk is concentrated in a single code and service type. This narrow service-line footprint implies limited diversification: any changes to coverage, coding, or reimbursement for K1034 would materially affect the provider's overall business performance.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 592,870 | $10 | $7.1M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 2 | 1,090 | 560 | $10 | $64.6K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 840 | $1 | $1.7K |
How this provider's Medicaid billing volume and revenue compare to other Michigan providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Michigan median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 4 | 10 | 310 | $1 | $2.6K |
Other providers in the same ZIP code as Bioprecision Laboratories, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Centria Healthcare LLC | MI | Home Health Agency | $0 | $591M |
| Area Agency On Aging 1-b | MI | Case Management Agency | $0 | $143.1M |
| Michigan Healthcare Professionals PC | MI | Internal Medicine Physician | $0 | $106.2M |
| Glendale Neurological Associates P C | MI | Neurology Physician | $0 | $52.6M |
| Centria Healthcare | MI | Clinic/Center | $0 | $10.1M |
| Martin Belkin | MI | Neurology Physician | $4.7M | $0 |
| Joshua Grant | MI | Ophthalmology Physician | $1.3M | $0 |
| Michigan Endoscopy Center LLC | MI | Ambulatory Surgical Clinic/Center | $1M | $11.9K |
| Ronald Bergman | MI | Ophthalmology Physician | $593.7K | $0 |
| Aaron Ellenbogen | MI | Neurology Physician | $549.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.